Remove 2016 Remove Atrial Fibrillation Remove Diabetes
article thumbnail

Abstract 262: National Trends of 90?day Readmission Rates and Etiologies among Diabetics following Transient Ischemic Attack

Stroke: Vascular and Interventional Neurology

Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health problem with increasing prevalence. from 2016‐2019 and secondary diagnosis of T2DM. from 2016‐2019 and secondary diagnosis of T2DM. Of those patients, 35.43% (n=273,993) were diabetic and 64.57% (n=151,112) were non‐diabetic.

article thumbnail

Multi-Ethnic Study of Atherosclerosis Early Heart Failure Study: Rationale, Design, and Baseline Characteristics

Circulation: Heart Failure

Between 2016 and 2018, 3285 MESA participants from 6 field centers underwent comprehensive speckle-tracking echocardiography with passive leg raise maneuver, Kansas City Cardiomyopathy Questionnaire, 6-minute walk test, arterial stiffness assessment, and proteomics (including NT-proBNP [N-terminal pro-B-type natriuretic peptide]).Results:Median

article thumbnail

Abstract TMP78: Disparities in Experiencing Major Adverse Cardiovascular Events Among Survivors of Spontaneous Intracerebral Hemorrhage by Hematoma Location

Stroke Journal

Patients with atrial fibrillation had a higher risk of AIS (1.47, 1.18 - 1.84) and MACE (1.26, 1.07 - 1.49). Results:Among 10,652 ICH patients (median age [IQR]: 70 [58 - 80] years; 47.7% female; 43.2% lobar ICH), 3.3%, 3.1%, 0.5%, and 8.1%, respectively, experienced r-ICH, AIS, AMI, and MACE.

article thumbnail

Abstract 055: Reperfusion Therapy for Acute Ischemic Stroke in Cardiomyopathy Patients with Heart Failure: A NIS?based Analysis

Stroke: Vascular and Interventional Neurology

The National Inpatient Sample (NIS) database from 2016‐2019 for patients with a principal diagnosis of AIS using the ICD‐10 code I63 was queried. Outcome measures studied included prolonged length of stay (LOS), discharge disposition, and inpatient mortality.ResultsWe identified 2,939,160 patients with AIS between 2016 and 2019.

article thumbnail

Differing Efficacy of Dapagliflozin Versus Empagliflozin on the Risk of Incident Atrial Fibrillation in Patients With Type 2 Diabetes: A Real?World Observation Using a Nationwide, Population?Based Cohort

Journal of the American Heart Association

BackgroundMeta‐analyses of large clinical trials investigating SGLT2 (sodium‐glucose cotransporter‐2) inhibitors have suggested their protective effects against atrial fibrillation in patients with type 2 diabetes. An active‐comparator, new‐user design was used, and the 2 groups of patients were matched using propensity scores.

article thumbnail

How To Test For Insulin Resistance

Dr. Paddy Barrett

Just for clarity, type 2 diabetes is when insulin resistance progresses to the point that your body can no longer keep your blood glucose levels under control. So if you have type 2 diabetes, you, by definition, are insulin resistant. For each additional feature, the likelihood and likely severity of insulin resistance increases.

article thumbnail

Abstract WMP86: Mechanical Thrombectomy Frequency and Outcomes in Acute Ischemic Stroke With Mild Deficits in the Unites States

Stroke Journal

0.90], P<0.001), history of atrial fibrillation (OR, 1.27 [95% CI, 1.01-1.60], 1.60], P<0.001), and absence of diabetes (OR, 0.77 [95% CI, 0.60-0.98], Patient and hospital-level characteristics associated with use and outcome of reperfusion therapies were analyzed. 0.98], P<0.001).Conclusions:In

Stroke 40